NDC 71335-2321 – Phenazopyridine Hydrochloride

Phenazopyridine Hydrochloride 200 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC71335-2321

Product details

Brand name
Phenazopyridine Hydrochloride
Generic name
Phenazopyridine Hydrochloride
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
UNAPPROVED DRUG OTHER
Marketed since
October 19, 2023
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Phenazopyridine Hydrochloride →

Package NDC codes (9)

Package NDCDescriptionSince
71335-2321-19 TABLET in 1 BOTTLE (71335-2321-1)Jan 4, 2024
71335-2321-220 TABLET in 1 BOTTLE (71335-2321-2)Jan 4, 2024
71335-2321-330 TABLET in 1 BOTTLE (71335-2321-3)Jan 4, 2024
71335-2321-410 TABLET in 1 BOTTLE (71335-2321-4)Jan 4, 2024
71335-2321-515 TABLET in 1 BOTTLE (71335-2321-5)Jan 4, 2024
71335-2321-66 TABLET in 1 BOTTLE (71335-2321-6)Jan 4, 2024
71335-2321-790 TABLET in 1 BOTTLE (71335-2321-7)Jan 4, 2024
71335-2321-812 TABLET in 1 BOTTLE (71335-2321-8)Jan 4, 2024
71335-2321-918 TABLET in 1 BOTTLE (71335-2321-9)Jan 4, 2024

Other Phenazopyridine Hydrochloride products